DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,203 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $223,042 | -7.0% | 899 | -10.0% | 0.08% | -4.9% |
Q2 2023 | $239,760 | -85.4% | 999 | -84.6% | 0.08% | -87.8% |
Q1 2023 | $1,639,016 | -19.4% | 6,503 | -15.1% | 0.67% | -34.3% |
Q4 2022 | $2,033,913 | -73.2% | 7,663 | -73.9% | 1.02% | -60.1% |
Q3 2022 | $7,593,000 | +2.0% | 29,397 | +0.1% | 2.56% | +5.9% |
Q2 2022 | $7,443,000 | -22.2% | 29,359 | -10.0% | 2.42% | +24.9% |
Q1 2022 | $9,567,000 | +47.4% | 32,615 | +64.8% | 1.94% | +71.8% |
Q4 2021 | $6,492,000 | +1.4% | 19,789 | -7.9% | 1.13% | -18.4% |
Q3 2021 | $6,402,000 | +5.2% | 21,475 | -5.3% | 1.38% | +1.5% |
Q2 2021 | $6,086,000 | +7.0% | 22,680 | -10.3% | 1.36% | -14.3% |
Q1 2021 | $5,690,000 | -9.4% | 25,280 | -10.6% | 1.59% | -22.6% |
Q4 2020 | $6,282,000 | +153.0% | 28,280 | +145.3% | 2.05% | +75.1% |
Q3 2020 | $2,483,000 | -7.5% | 11,531 | -24.0% | 1.17% | -27.5% |
Q2 2020 | $2,684,000 | +8033.3% | 15,181 | +4960.3% | 1.62% | +5675.0% |
Q3 2018 | $33,000 | -15.4% | 300 | -25.0% | 0.03% | -30.0% |
Q2 2018 | $39,000 | 0.0% | 400 | 0.0% | 0.04% | -7.0% |
Q1 2018 | $39,000 | -81.3% | 400 | -82.2% | 0.04% | -80.2% |
Q4 2017 | $209,000 | – | 2,250 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |